Greaves Cotton Limited has announced a scheduled plant visit for investors and analysts at its manufacturing facility in Chhatrapati Sambhajinagar. The company made this disclosure on March 17, 2026, in compliance with regulatory requirements under SEBI listing obligations.

Plant Visit Details

The company has organized a comprehensive facility tour for stakeholders to provide them with firsthand insights into its manufacturing operations. The visit is structured as a group interaction, allowing multiple participants to engage simultaneously.

Regulatory Compliance

The announcement was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates listed companies to disclose material events and information that could impact investor decisions, including scheduled interactions with stakeholders.

The company has indicated that the schedule remains subject to potential changes due to exigencies that may arise from either the investors' side or the company's operational requirements. Such flexibility is standard practice for corporate events to accommodate unforeseen circumstances.

Corporate Communication

The disclosure was signed by Atindra Basu, Group General Counsel & Company Secretary, who holds ICSI Membership No. F13799. The communication was addressed to both major stock exchanges where the company's shares are listed, ensuring comprehensive regulatory compliance and transparency with all stakeholders.

Greaves Cotton Limited has announced the approval of employee stock options under its ESOP 2024 scheme. The Nomination and Remuneration Committee of the Board of Directors approved the grant during its meeting held on March 13, 2026, demonstrating the company's commitment to employee incentivization and retention.

Stock Option Grant Details

The committee has approved the grant of up to 3,05,307 stock options to eligible employees under the Greaves Cotton Employee Stock Option Plan 2024. This grant is structured in compliance with SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021 as amended from time to time.

Regulatory Compliance and Disclosure

The company has clarified that this grant of options under ESOP 2024 is not considered a material event under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The disclosure has been made purely for shareholder information and to ensure transparency in corporate governance practices.

The stock options grant follows the regulatory framework established by SEBI Master Circular HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, ensuring full compliance with current regulations governing employee benefit schemes.

Key Terms and Conditions

The equity shares to be allotted upon exercise of these stock options will rank pari-passu with existing equity shares of the company. The vesting of stock options will occur within the specified vesting period as outlined in the ESOP 2024 scheme, with a mandatory minimum period of one year between grant and vesting.

• Fresh equity shares will be issued upon exercise of vested options
• Each option converts to one equity share of Rs. 2 face value
• Options must be exercised within 8 years of vesting
• Vesting schedule follows ESOP 2024 guidelines

The announcement was made through a formal intimation to both BSE Limited and National Stock Exchange of India Limited, signed by Atindra Basu, Group General Counsel and Company Secretary. This employee stock option grant reflects the company's strategy to align employee interests with long-term shareholder value creation.